Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Agricultural Inputs

Arcadia Biosciences, Inc., a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company`s crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; nutritional oils; and HB4, a drought and herbicide tolerant soybean trait. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Canada, Africa, and India. The company was founded in 2002 and is headquartered in Davis, California.
Website: arcadiabio.com



Growth: Bad revenue growth rate 0.0%, there is slowdown compared to average historical growth rates 64.2%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is negative, -216.7%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 80% of quarters (showing a gain of +$1.94 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -151.0% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is -1.8% higher than minimum and 98.2% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued -6.7x by EV / Sales multiple

Key Financials (Download financials)

Ticker: RKDA
Share price, USD:  (-3.9%)2.21
year average price 3.82  


year start price 7.87 2023-03-30

max close price 7.87 2023-03-30

min close price 2.25 2024-03-22

current price 2.21 2024-03-29
Common stocks: 599 389

Dividend Yield:  0.0%
Last revenue growth (y/y):  0.0%
Last growth of EBITDA (y/y):  ---
Historical revenue growth:  64.2%
Historical growth of EBITDA:  ---
EV / Sales: -1.6x
Margin (EBITDA LTM / Revenue): -216.7%
Fundamental value created in LTM:
Market Cap ($m): 1
Net Debt ($m): -11
EV (Enterprise Value): -10
Price to Book: 0.1x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2023-11-10Seeking Alpha

Arcadia Biosciences, Inc. (RKDA) Q3 2023 Earnings Call Transcript

2023-10-26Business Wire

Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2023 Financial Results and Business Highlights Conference Call

2023-09-05Business Wire

Arcadia Biosciences (RKDA) to Participate in Upcoming Investor Conferences

2023-08-10Zacks Investment Research

Arcadia Biosciences (RKDA) Reports Q2 Loss, Misses Revenue Estimates

2023-07-27Business Wire

Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2023 Financial Results and Business Highlights Conference Call

2023-05-11Seeking Alpha

Arcadia Biosciences, Inc. (RKDA) Q1 2023 Earnings Call Transcript

2023-04-28Business Wire

Arcadia Biosciences (RKDA) Announces Date of First Quarter 2023 Financial Results and Business Highlights Conference Call
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol RKDA RKDA RKDA RKDA RKDA RKDA
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2023-11-09 2023-08-10 2023-05-15 2023-03-30 2022-11-10 2022-08-11
acceptedDate 2023-11-09 17:03:55 2023-08-10 17:09:15 2023-05-15 16:08:46 2023-03-30 17:09:24 2022-11-10 16:53:05 2022-08-11 17:09:18
calendarYear 2023.000 2023.000 2023.000 2022.000 2022.000 2022.000
period Q3 Q2 Q1 Q4 Q3 Q2
revenue 2M 1M 2M 1 000 000 2M 4M
costOfRevenue 1M 981 000 825 000 2M 1M 3M
grossProfit 495 000 408 000 684 000 -552 000 534 000 411 000
grossProfitRatio 0.310 0.294 0.453 -0.552 0.284 0.107
researchAndDevelopmentExpenses 305 000 391 000 359 000 500 000 255 000 359 000
generalAndAdministrativeExpenses 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 3M 4M 4M 4M 5M 5M
otherExpenses 17 000 -13 000 32 000 20 000 0 0
operatingExpenses 4M 4M 5M 5M 5M 5M
costAndExpenses 5M 5M 6M 6M 6M 8M
interestIncome 133 000 207 000 0 0 0 0
interestExpense 0 0 198 000 194 000 95 000 30 000
depreciationAndAmortization 89 000 67 000 -38 000 -115 000 -2M 141 000
ebitda -3M -8M -4M -6M -6M -4M
ebitdaratio -2.030 -5.870 -2.708 -5.945 -3.366 -0.940
operatingIncome -3M -4M -4M -6M -5M -4M
operatingIncomeRatio -2.030 -2.729 -2.683 -5.830 -2.426 -0.981
totalOtherIncomeExpensesNet 758 000 4M 19 000 2M 2M -14 000
incomeBeforeTax -2M 819 000 -4M -4M -3M -4M
incomeBeforeTaxRatio -1.555 0.590 -2.683 -4.315 -1.531 -0.984
incomeTaxExpense 83 000 1000.000 -198 000 13 000 1000.000 -20 000
netIncome -3M 823 000 -4M -4M -3M -4M
netIncomeRatio -1.607 0.593 -2.551 -4.328 -1.532 -0.979
eps -1.890 0.610 -4.490 -7.220 -4.690 -0.170
epsdiluted -1.890 0.610 -4.490 -7.220 -4.690 -0.170
weightedAverageShsOut 1M 1M 857 572 599 389 613 813 22M
weightedAverageShsOutDil 1M 1M 857 572 599 389 613 813 22M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol RKDA RKDA RKDA RKDA RKDA RKDA
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2023-11-09 2023-08-10 2023-05-15 2023-03-30 2022-11-10 2022-08-11
acceptedDate 2023-11-09 17:03:55 2023-08-10 17:09:15 2023-05-15 16:08:46 2023-03-30 17:09:24 2022-11-10 16:53:05 2022-08-11 17:09:18
calendarYear 2023.000 2023.000 2023.000 2022.000 2022.000 2022.000
period Q3 Q2 Q1 Q4 Q3 Q2
cashAndCashEquivalents 11M 13M 23M 21M 23M 21M
shortTermInvestments 5M 5M 0 0 0 0
cashAndShortTermInvestments 16M 19M 23M 21M 23M 21M
netReceivables 304 000 630 000 923 000 1M 3M 4M
inventory 3M 3M 3M 3M 3M 3M
otherCurrentAssets 1M 951 000 606 000 809 000 990 000 2M
totalCurrentAssets 20M 23M 27M 25M 30M 30M
propertyPlantEquipmentNet 2M 2M 2M 3M 3M 3M
goodwill 0 0 0 0 0 0
intangibleAssets 40 000 40 000 40 000 40 000 373 000 386 000
goodwillAndIntangibleAssets 40 000 40 000 40 000 40 000 373 000 386 000
longTermInvestments 0 0 0 0 0 0
taxAssets 0 0 0 0 0 0
otherNonCurrentAssets 2M 1M 925 000 932 000 1M 1M
totalNonCurrentAssets 3M 3M 3M 4M 4M 5M
otherAssets 0 0 0 0 0 0
totalAssets 23M 27M 30M 29M 34M 35M
accountPayables 3M 3M 3M 931 000 3M 3M
shortTermDebt 924 000 993 000 1M 1M 986 000 994 000
taxPayables 0 0 0 0 0 0
deferredRevenue 46 000 33 000 0 0 0 0
otherCurrentLiabilities 313 000 282 000 298 000 2M 317 000 355 000
totalCurrentLiabilities 4M 4M 4M 4M 4M 5M
longTermDebt 347 000 532 000 760 000 1M 1M 2M
deferredRevenueNonCurrent 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0
otherNonCurrentLiabilities 4M 4M 9M 3M 2M 2M
totalNonCurrentLiabilities 4M 5M 10M 4M 5M 4M
otherLiabilities 0 0 0 0 0 0
capitalLeaseObligations 1M 2M 2M 2M 2M 2M
totalLiabilities 8M 9M 14M 8M 9M 8M
preferredStock 2M 0 0 0 0 0
commonStock 65 000 65 000 65 000 65 000 65 000 63 000
retainedEarnings -269M -266M -267M -258M -254M -251M
accumulatedOtherComprehensiveIncomeLoss 87 000 21 000 0 0 0 0
othertotalStockholdersEquity 283M 284M 284M 279M 279M 277M
totalStockholdersEquity 16M 18M 17M 21M 25M 27M
totalEquity 15M 18M 17M 21M 25M 27M
totalLiabilitiesAndStockholdersEquity 23M 27M 30M 29M 34M 35M
minorityInterest -138 000 -138 000 -133 000 -133 000 0 0
totalLiabilitiesAndTotalEquity 23M 27M 30M 29M 34M 35M
totalInvestments 5M 5M 0 0 0 0
totalDebt 1M 2M 2M 2M 2M 2M
netDebt -9M -12M -21M -19M -20M -19M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol RKDA RKDA RKDA RKDA RKDA RKDA
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2023-11-09 2023-08-10 2023-05-15 2023-03-30 2022-11-10 2022-08-11
acceptedDate 2023-11-09 17:03:55 2023-08-10 17:09:15 2023-05-15 16:08:46 2023-03-30 17:09:24 2022-11-10 16:53:05 2022-08-11 17:09:18
calendarYear 2023.000 2023.000 2023.000 2022.000 2022.000 2022.000
period Q3 Q2 Q1 Q4 Q3 Q2
netIncome -3M 818 000 -9M -4M -3M -4M
depreciationAndAmortization 89 000 67 000 71 000 86 000 90 000 141 000
deferredIncomeTax -796 000 -10M 0 0 0 0
stockBasedCompensation 162 000 199 000 212 000 209 000 314 000 323 000
changeInWorkingCapital -381 000 -2M -115 000 2M 1M -2M
accountsReceivables 162 000 7000.000 80 000 1M 2M -1M
inventory -72 000 -1M -37 000 47 000 70 000 332 000
accountsPayables -151 000 0 -149 000 133 000 -643 000 -49 000
otherWorkingCapital -320 000 -532 000 -9000.000 901 000 -304 000 0
otherNonCashItems 608 000 6M 6M -530 000 -2M 1M
netCashProvidedByOperatingActivities -3M -5M -3M -2M -3M -3M
investmentsInPropertyPlantAndEquipment 0 -5000.000 0 -26 000 0 -6000.000
acquisitionsNet 5000.000 284 000 285 000 284 000 285 000 0
purchasesOfInvestments 0 -5M 0 0 0 0
salesMaturitiesOfInvestments 0 5M 0 0 0 0
otherInvestingActivites 0 -5M 30 000 23 000 56 000 54 000
netCashUsedForInvestingActivites 5000.000 -5M 315 000 281 000 341 000 48 000
debtRepayment -382 000 -191 000 0 -932 000 0 -446 000
commonStockIssued 7000.000 0 6M 0 5M 0
commonStockRepurchased 0 85M 0 0 0 0
dividendsPaid 0 0 0 0 0 0
otherFinancingActivites 382 000 191 000 -492 000 936 000 -485 000 446 000
netCashUsedProvidedByFinancingActivities 7000.000 85M 6M 4000.000 5M 0
effectOfForexChangesOnCash 0 -85M 0 -4000.000 0 0
netChangeInCash -3M -10M 2M -2M 1M -3M
cashAtEndOfPeriod 11M 13M 23M 21M 23M 21M
cashAtBeginningOfPeriod 13M 23M 21M 23M 21M 25M
operatingCashFlow -3M -5M -3M -2M -3M -3M
capitalExpenditure 0 -5000.000 0 -26 000 0 -6000.000
freeCashFlow -3M -5M -3M -2M -3M -3M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Earning call transcript

2023 q3
2023-11-10 ET (fiscal 2023 q3)
2023 q2
2023-08-10 ET (fiscal 2023 q2)
2023 q1
2023-05-11 ET (fiscal 2023 q1)
2022 q4
2023-03-30 ET (fiscal 2022 q4)
2022 q3
2022-11-10 ET (fiscal 2022 q3)
2022 q2
2022-08-11 ET (fiscal 2022 q2)
2022 q1
2022-05-12 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-03-14 12:02 ET
Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2023 Financial Results and Business Highlights Conference Call
2024-02-20 13:02 ET
Arcadia Biosciences (RKDA) Expands GoodWheat™ Mac & Cheese with Nationwide Availability
2023-11-09 21:05 ET
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2023 Financial Results and Business Highlights
2023-10-26 12:02 ET
Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2023 Financial Results and Business Highlights Conference Call
2023-10-03 12:02 ET
GoodWheat™ Introduces Clean Plate Guarantee, Celebrates Picky Eaters for National Pasta Month
2023-09-05 12:02 ET
Arcadia Biosciences (RKDA) to Participate in Upcoming Investor Conferences
2023-08-10 20:05 ET
Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2023 Financial Results and Business Highlights
2023-07-27 14:19 ET
Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2023 Financial Results and Business Highlights Conference Call
2023-07-20 12:02 ET
Arcadia Biosciences (RKDA) Announces Strategic Review
2023-07-17 12:02 ET
Arcadia Biosciences (RKDA) Launches GoodWheat™ into the Breakfast Category with New Better-For-You Pancake & Waffle Mixes and Single-Serve Quikcakes™
2023-05-11 20:05 ET
Arcadia Biosciences (RKDA) Announces First Quarter 2023 Financial Results from Operations and Business Highlights
2023-05-08 12:01 ET
GoodWheat™ Pasta Named “Best New Product” By Retail Dietitians Business Alliance
2023-04-28 12:02 ET
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2023 Financial Results and Business Highlights Conference Call
2023-03-30 20:05 ET
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2022 Financial Results and Business Highlights
2023-03-22 12:02 ET
Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2022 Financial Results and Business Highlights Conference Call
2023-03-03 00:00 ET
Arcadia Biosciences (RKDA) Announces $6.0 Million Private Placement Priced at a Premium to Market Under Nasdaq Rules
2023-01-18 13:00 ET
GoodWheat™ Pasta Receives American Heart Association® Heart-Check Certification
2022-12-08 13:00 ET
Arcadia Biosciences (RKDA) Doubles Retail Footprint for GoodWheat™ Pasta
2022-11-30 21:30 ET
Arcadia Biosciences (RKDA) Announces CFO Transition
2022-11-10 21:05 ET
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2022 Financial Results and Business Highlights
2022-10-27 12:00 ET
Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2022 Financial Results and Business Highlights Conference Call
2022-08-31 12:00 ET
Arcadia Biosciences (RKDA) to Participate in Upcoming Investor Conferences
2022-08-12 23:10 ET
Arcadia Biosciences (RKDA) Announces $5.0 Million Registered Direct Offering Priced At-The-Market
2022-08-11 20:05 ET
Arcadia Biosciences (RKDA) Announces Strong Second-Quarter and First-Half 2022 Financial Results and Business Highlights
2022-07-28 12:00 ET
Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2022 Financial Results and Business Highlights Conference Call
2022-06-01 13:00 ET
NEW GOODWHEAT™ PASTA SERVES UP PASTA REVOLUTION WITH FORKFUL OF FIBER THAT NEVER TASTED SO GOOD
2022-05-12 20:05 ET
Arcadia Biosciences (RKDA) Announces First Quarter 2022 Financial Results
2022-05-05 12:00 ET
Arcadia Biosciences Announces Date of First Quarter 2022 Financial Results and Business Highlights Conference Call
2022-03-30 20:05 ET
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2021 Financial Results and Business Highlights
2022-03-23 12:00 ET
Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2021 Financial Results and Business Highlights Conference Call
2022-02-02 21:05 ET
Arcadia Biosciences (RKDA) Names Stan Jacot as CEO
2021-12-20 15:55 ET
Arcadia Biosciences (RKDA) Appoints Kevin Comcowich to Interim CEO
2021-11-22 13:00 ET
Arcadia Biosciences (RKDA) Appoints Seasoned CPG Sales Executive Brian Schaffer to Senior Vice President of Sales
2021-11-15 21:05 ET
Arcadia Biosciences (RKDA) Announces Strong Third-Quarter Financial Results and Business Highlights
2021-11-08 13:00 ET
Arcadia Biosciences (RKDA) Announces Date of Third-Quarter 2021 Financial Results and Business Highlights Conference Call
2021-09-07 20:10 ET
Arcadia Biosciences Announces Leadership Transition
2021-08-16 20:05 ET
Arcadia Biosciences Announces Strong Second-Quarter and First-Half 2021 Financial Results and Business Highlights
2021-08-09 12:00 ET
Arcadia Biosciences (RKDA) Announces Date of Second-Quarter and First-Half 2021 Financial Results and Business Highlights Conference Call
2021-07-20 11:00 ET
Arcadia Biosciences (RKDA) Names Veteran CPG Leader Laura Pitlik Chief Marketing Officer
2021-05-17 20:05 ET
Arcadia Biosciences (RKDA) Announces First-Quarter 2021 Financial Results and Business Highlights
2021-05-17 20:02 ET
Arcadia Biosciences (RKDA) Acquires Lief Brands, a Portfolio of CBD and Wellness Brands
2021-05-10 12:30 ET
Arcadia Biosciences Announces Date of First Quarter 2021 Financial Results and Business Highlights Conference Call
2021-05-10 12:00 ET
Belinda Yao joins Arcadia Biosciences (RKDA) as Vice President of Operations
2021-04-20 12:00 ET
Arcadia Biosciences (RKDA) Receives Health Canada Approval for GoodHemp™ Varieties
2021-04-19 12:00 ET
Arcadia Biosciences (RKDA) Acquires European Food Ingredient Platform that Further Enhances its GoodWheat™ Business
2021-03-30 20:05 ET
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2020 Financial Results and Business Highlights
2021-03-23 12:00 ET
Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2020 Financial Results and Business Highlights Conference Call
2021-03-04 13:00 ET
Arcadia Biosciences (RKDA) Expands GoodWheat™ Patent Portfolio
2021-03-02 13:00 ET
Arcadia Biosciences (RKDA) to Present at H.C. Wainwright's Global Life Sciences Conference March 9-10, 2021
2021-02-24 18:04 ET
Arcadia Biosciences Welcomes Debbie Carosella to Board Of Directors
2021-02-02 13:00 ET
GoodHemp™ Seed Varieties Earn AOSCA Certification
2021-01-25 14:00 ET
Arcadia Biosciences (RKDA) Announces $25.1 Million Private Placement
2020-12-18 14:02 ET
Arcadia Biosciences (RKDA) Announces $8.0 Million Registered Direct Offering Priced At-the-Market
2020-11-24 13:00 ET
Arcadia Biosciences (RKDA) Signs Hemp Distribution Agreement with Tritium 3H
2020-11-12 13:05 ET
Arcadia Biosciences (RKDA) Announces a Series of Strategic Transactions with Bioceres Crop Solutions (BIOX)
2020-11-12 13:00 ET
Arcadia Biosciences (RKDA) Announces Third-Quarter 2020 Financial Results and Business Highlights
2020-11-10 13:00 ET
Three Farm Daughters™ Launches New Product Portfolio Powered by GoodWheat™
2020-11-06 13:00 ET
Arcadia Biosciences Announces Date of Third Quarter 2020 Financial Results and Business Highlights Conference Call
2020-09-17 12:00 ET
Arcadia Biosciences (RKDA) Expands Leadership Team with New Heads of Commercial Operations and Product Innovation
2020-09-09 12:00 ET
Arcadia Biosciences (RKDA) to Present at H.C. Wainwright's 22nd Annual Global Investment Conference September 14-16, 2020
2020-09-01 12:00 ET
Arcadia Biosciences (RKDA) Completes Purchase of Industrial Seed Innovations, Acquires Proprietary Hemp Varieties
2020-08-13 20:05 ET
Arcadia Biosciences Announces Second-Quarter and First-Half 2020 Financial Results and Business Highlights
2020-08-12 12:00 ET
Arcadia Biosciences (RKDA) Collaborates with GoodMills Innovation to Sell GoodWheat™ in Europe
2020-08-10 12:00 ET
Arcadia Biosciences (RKDA) Announces Partnership with Three Farm Daughters to Develop and Market GoodWheat™-Branded Wheat Products
2020-08-06 12:00 ET
Arcadia Biosciences Announces Collaboration with Corner Foods to Commercialize GoodWheat™ Technology
2020-07-30 15:00 ET
Arcadia Biosciences Announces Date of Second Quarter and First Half 2020 Financial Results and Business Highlights Conference Call
2020-07-06 13:23 ET
Arcadia Biosciences Announces Warrant Exercise Transaction to Generate $2.5 Million in Gross Proceeds
2020-06-18 12:00 ET
Arcadia Biosciences Receives Foundational Patents for Non-GMO Herbicide Tolerant Wheat Traits
2020-06-17 12:00 ET
Arcadia Biosciences to Join Russell Microcap® Index
2020-06-10 12:00 ET
Arcadia Biosciences Announces Plans to Acquire Oregon-Based Industrial Seed Innovations
2020-05-18 15:30 ET
Arcadia Biosciences Announces Cash Proceeds of $6.8 Million from Warrant Exercise
2020-05-13 20:05 ET
Arcadia Biosciences Announces First-Quarter 2020 Financial Results and Business Highlights
2020-05-07 12:00 ET
Arcadia Biosciences Significantly Expands Intellectual Property Portfolio with Four U.S. Patents
2020-05-06 12:00 ET
Arcadia Biosciences Announces Date of First Quarter 2020 Financial Results and Business Highlights Conference Call
2020-04-01 12:00 ET
Arcadia Biosciences Promotes Randy Shultz, Ph.D. to Chief Technology Officer
2020-03-25 20:05 ET
Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights
2020-03-23 12:00 ET
Arcadia Biosciences and Archipelago Ventures Announce Strategic Partnership with Vivion Specialties, Inc. to Certify and Distribute Hawaiian Hemp Products Across North America
2020-03-19 12:00 ET
Arcadia Biosciences Partners with Grow West® and Buttonwillow Warehouse Company to Bring GoodHemp Seeds to California Growers
2020-03-11 12:00 ET
Arcadia Biosciences Announces Date of Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights Conference Call
2020-03-10 12:00 ET
Verdeca Showcases HB4® Drought Tolerant Soybeans to Growers and Enrolls Early Adopters at Expoagro in Argentina
2020-02-27 13:00 ET
Arcadia Biosciences Receives U.S. Patent for High Fiber Wheat with Improved Yield
2020-01-30 15:00 ET
Arcadia Biosciences Announces Over $3 Million in Pre-Season GoodHemp Seed Purchase Commitments
2020-01-30 13:00 ET
Arcadia Biosciences Letter to Shareholders
2019-11-12 13:00 ET
Verdeca Receives Approval of HB4® Drought and Herbicide Tolerant Soybeans in Paraguay
2019-11-05 09:00 ET
Arcadia Biosciences Announces Wheat Purchase Commitment, Significant Increase in GoodWheat(TM) Harvest Acres
2019-10-30 12:00 ET
Arcadia Biosciences Announces Date of Third-Quarter 2019 Financial Results and Business Highlights Conference Call
2019-10-15 08:00 ET
Arcadia Biosciences Advances Hemp Operations with Archipelago Ventures
2019-09-23 13:31 ET
Thinking about buying stock in Aurora Cannabis, Beyond Meat, Exact Sciences, Plus Therapeutics, or Arcadia Biosciences?
2019-09-23 08:00 ET
Arcadia Biosciences Granted U.S. Patent for Reduced Gluten GoodWheat
2019-09-10 15:37 ET
Arcadia Biosciences Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market
2019-09-05 08:00 ET
Arcadia Specialty Genomics(TM) Expands Hemp Operations with New Sun-Grown Cultivation and Research Facility in California
2019-09-04 12:00 ET
Arcadia Biosciences to Present at 21st Annual Global Investment Conference September 8-10, 2019
2019-08-26 08:15 ET
Arcadia Biosciences Announces Management Succession; Provides Financial Guidance
2019-08-26 08:00 ET
Arcadia Biosciences Enters Global Collaboration with Arista Cereal Technologies and Bay State Milling Company for Commercialization of High Fiber Wheat
2019-08-15 13:31 ET
Thinking about buying stock in Aurora Cannabis, Alibaba, Canopy Growth, Arcadia Biosciences, or Walmart?
2019-08-14 20:08 ET
Arcadia Biosciences Announces Second-Quarter and First-Half 2019 Financial Results and Business Highlights
2019-08-12 13:31 ET
Thinking about buying stock in Aurora Cannabis, Arcadia Biosciences, Roku, Tilray, or Yangtze River Port and Logistics?
2019-08-09 13:31 ET
Thinking about buying stock in Aurora Cannabis, Activision Blizzard, Arcadia Biosciences, Tilray, or Uber Technologies?
2019-08-09 00:30 ET
Verdeca Receives USDA Approval of HB4® Drought Tolerant Soybeans
2019-08-06 12:45 ET
Arcadia Biosciences Announces Joint Venture with Legacy Ventures Hawaii To Grow, Extract and Sell Superior Hemp Products
2019-08-05 20:37 ET
Arcadia Biosciences Announces Date of Second-Quarter 2019 Financial Results and Business Highlights Conference Call
2019-06-18 13:00 ET
Arcadia Biosciences Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market
2019-06-13 13:00 ET
Arcadia Biosciences Announces $7.5 Million Registered Direct Offering Priced At-the-Market
ET
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2023 Financial Results and Business Highlights

SEC forms

Show financial reports only

SEC form 8
2024-03-28 17:02 ET
Arcadia Biosciences reported for 2023 q4
SEC form 8
2024-03-28 17:02 ET
Arcadia Biosciences published news for 2023 q4
SEC form 8
2024-03-28 17:02 ET
Arcadia Biosciences published news for 2023 q4
SEC form 10
2023-11-09 17:03 ET
Arcadia Biosciences reported for 2023 q3
SEC form 8
2023-11-09 16:10 ET
Arcadia Biosciences published news for 2023 q3
SEC form 10
2023-11-09 00:00 ET
Arcadia Biosciences published news for 2023 q3
SEC form 10
2023-08-10 17:09 ET
Arcadia Biosciences published news for 2023 q2
SEC form 6
2023-08-10 16:19 ET
Arcadia Biosciences reported for 2023 q2
SEC form 10
2023-08-10 00:00 ET
Arcadia Biosciences published news for 2023 q2
SEC form 8
2023-08-10 00:00 ET
Arcadia Biosciences published news for 2023 q2
SEC form 6
2023-07-20 14:55 ET
Arcadia Biosciences published news for 2023 q2
SEC form 8
2023-07-20 00:00 ET
Arcadia Biosciences published news for 2023 q2
SEC form 6
2023-06-12 16:12 ET
Arcadia Biosciences published news for 2023 q1
SEC form 10
2023-05-15 00:00 ET
Arcadia Biosciences published news for 2023 q1
SEC form 6
2023-05-11 16:26 ET
Arcadia Biosciences published news for 2023 q1
SEC form 8
2023-05-11 00:00 ET
Arcadia Biosciences published news for 2023 q1
SEC form 6
2023-04-13 16:07 ET
Arcadia Biosciences published news for 2023 q1
SEC form 10
2023-03-30 17:09 ET
Arcadia Biosciences reported for 2022 q4
SEC form 6
2023-03-30 16:07 ET
Arcadia Biosciences published news for 2022 q4
SEC form 10
2023-03-30 00:00 ET
Arcadia Biosciences reported for 2022 q4
SEC form 8
2023-03-30 00:00 ET
Arcadia Biosciences reported for 2022 q4
SEC form 6
2023-03-03 16:16 ET
Arcadia Biosciences published news for 2022 q4
SEC form 6
2023-02-28 16:12 ET
Arcadia Biosciences published news for 2022 q4
SEC form 6
2023-02-22 16:10 ET
Arcadia Biosciences published news for 2022 q4
SEC form 6
2023-01-06 16:11 ET
Arcadia Biosciences published news for 2022 q4
SEC form 6
2023-01-05 16:14 ET
Arcadia Biosciences published news for 2022 q4
SEC form 6
2022-12-23 16:12 ET
Arcadia Biosciences published news for 2022 q3
SEC form 6
2022-12-08 16:18 ET
Arcadia Biosciences published news for 2022 q3
SEC form 6
2022-11-30 16:32 ET
Arcadia Biosciences published news for 2022 q3
SEC form 10
2022-11-10 16:53 ET
Arcadia Biosciences reported for 2022 q3
SEC form 6
2022-11-10 16:11 ET
Arcadia Biosciences published news for 2022 q3
SEC form 8
2022-11-10 00:00 ET
Arcadia Biosciences reported for 2022 q3
SEC form 10
2022-11-10 00:00 ET
Arcadia Biosciences reported for 2022 q3
SEC form 6
2022-09-27 16:46 ET
Arcadia Biosciences published news for 2022 q2
SEC form 6
2022-08-16 17:00 ET
Arcadia Biosciences published news for 2022 q2
SEC form 10
2022-08-11 17:09 ET
Arcadia Biosciences reported for 2022 q2
SEC form 6
2022-08-11 16:07 ET
Arcadia Biosciences published news for 2022 q2
SEC form 8
2022-08-11 00:00 ET
Arcadia Biosciences reported for 2022 q2
SEC form 10
2022-08-11 00:00 ET
Arcadia Biosciences reported for 2022 q2
SEC form 6
2022-06-07 16:44 ET
Arcadia Biosciences published news for 2022 q1
SEC form 10
2022-05-12 16:59 ET
Arcadia Biosciences reported for 2022 q1
SEC form 6
2022-05-12 16:07 ET
Arcadia Biosciences published news for 2022 q1
SEC form 10
2022-05-12 00:00 ET
Arcadia Biosciences reported for 2022 q1
SEC form 8
2022-05-12 00:00 ET
Arcadia Biosciences reported for 2022 q1
SEC form 6
2022-04-19 13:51 ET
Arcadia Biosciences published news for 2022 q1
SEC form 10
2022-03-31 17:30 ET
Arcadia Biosciences published news for 2021 q4
SEC form 10
2022-03-31 00:00 ET
Arcadia Biosciences published news for 2021 q4
SEC form 6
2022-03-30 16:09 ET
Arcadia Biosciences published news for 2021 q4
SEC form 8
2022-03-30 00:00 ET
Arcadia Biosciences published news for 2021 q4
SEC form 6
2022-02-07 16:26 ET
Arcadia Biosciences published news for 2021 q4
SEC form 6
2021-12-20 17:03 ET
Arcadia Biosciences published news for 2021 q3
SEC form 6
2021-11-19 16:29 ET
Arcadia Biosciences published news for 2021 q3
SEC form 10
2021-11-15 16:53 ET
Arcadia Biosciences published news for 2021 q3
SEC form 6
2021-11-15 16:08 ET
Arcadia Biosciences published news for 2021 q3
SEC form 10
2021-11-15 00:00 ET
Arcadia Biosciences published news for 2021 q3
SEC form 8
2021-11-15 00:00 ET
Arcadia Biosciences published news for 2021 q3
SEC form 6
2021-10-12 13:44 ET
Arcadia Biosciences published news for 2021 q3
SEC form 6
2021-09-07 16:48 ET
Arcadia Biosciences published news for 2021 q2
SEC form 10
2021-08-16 17:06 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-08-16 16:10 ET
Arcadia Biosciences published news for 2021 q2
SEC form 10
2021-08-16 00:00 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-08-02 16:57 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-07-20 16:00 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-07-06 16:02 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-07-02 15:32 ET
Arcadia Biosciences published news for 2021 q2
SEC form 6
2021-06-07 17:14 ET
Arcadia Biosciences published news for 2021 q1
SEC form 6
2021-05-21 15:59 ET
Arcadia Biosciences published news for 2021 q1
SEC form 10
2021-05-17 17:05 ET
Arcadia Biosciences published news for 2021 q1
SEC form 6
2021-05-17 16:10 ET
Arcadia Biosciences published news for 2021 q1
SEC form 10
2021-05-17 00:00 ET
Arcadia Biosciences published news for 2021 q1
SEC form 6
2021-04-20 15:01 ET
Arcadia Biosciences published news for 2021 q1
SEC form 10
2021-03-31 17:00 ET
Arcadia Biosciences published news for 2020 q4
SEC form 6
2021-03-30 16:51 ET
Arcadia Biosciences published news for 2020 q4
SEC form 6
2021-02-24 15:48 ET
Arcadia Biosciences published news for 2020 q4
SEC form 6
2021-01-29 11:34 ET
Arcadia Biosciences published news for 2020 q4
SEC form 6
2020-12-22 12:32 ET
Arcadia Biosciences published news for 2020 q3
SEC form 6
2020-11-18 15:44 ET
Arcadia Biosciences published news for 2020 q3
SEC form 10
2020-11-13 14:47 ET
Arcadia Biosciences published news for 2020 q3
SEC form 6
2020-11-12 08:00 ET
Arcadia Biosciences published news for 2020 q3